better
assess
risk
transmiss
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
obtain
serial
specimen
clinic
exposur
data
seven
confirm
us
sar
patient
household
contact
sarscov
detect
sputum
specimen
one
casepati
five
stool
specimen
two
casepati
one
casepati
sarscov
persist
stool
least
day
symptom
onset
highest
amount
viru
sputum
sampl
stool
sampl
residu
respiratori
symptom
still
present
recov
sar
casepati
month
ill
onset
possibl
transmiss
sarscov
occur
one
household
contact
person
also
travel
sarsaffect
area
data
suggest
sarscov
alway
transmit
effici
routin
collect
test
stool
sputum
specimen
probabl
sar
casepati
may
help
earli
detect
sarscov
infect
ever
acut
respiratori
syndrom
sar
recent
describ
clinic
manifest
infect
novel
coronaviru
cov
sarsassoci
cov
sarscov
syndrom
first
recogn
februari
vietnam
later
realiz
first
case
occur
southern
china
novemb
subsequ
infect
rapidli
spread
throughout
world
juli
world
health
organ
declar
outbreak
contain
case
death
countri
report
outbreak
develop
epidemiolog
evid
suggest
sarscov
transmit
respiratori
droplet
direct
contact
infect
patient
possibl
fomit
certain
circumst
transmiss
sarscov
particularli
effici
result
individu
patient
infect
larg
number
peopl
refer
superspread
event
wherea
situat
secondari
transmiss
observ
better
understand
durat
sarscov
shed
viru
quantiti
respiratori
secret
stool
urin
bodi
fluid
risk
factor
spread
ill
close
contact
critic
accur
assess
risk
transmiss
develop
effect
control
strategi
end
obtain
serial
biolog
specimen
clinic
exposur
data
week
onset
ill
seven
laboratoryconfirm
us
sar
patient
household
contact
target
patient
met
center
diseas
control
prevent
cdc
surveil
case
definit
probabl
sar
patient
laboratoryconfirm
sarscov
infect
antibodi
sarscov
detect
enrol
includ
confirm
sar
casepati
declin
particip
exclud
variou
reason
neg
sarscov
antibodi
day
ill
onset
confirm
altern
diagnosi
foreign
citizen
resid
unit
state
household
contact
seven
laboratoryconfirm
casepati
also
enrol
household
contact
defin
person
live
household
sar
casepati
ill
particip
provid
inform
consent
followup
visit
schedul
twice
week
first
week
ill
onset
week
week
casepati
first
enrol
week
ill
followup
visit
made
soon
feasibl
enrol
casepati
enrol
week
ill
onset
therefor
follow
week
household
contact
visit
schedul
weekli
period
week
initi
exposur
casepati
singl
followup
visit
schedul
household
contact
enrol
week
initi
exposur
casepati
initi
visit
sar
casepati
collect
data
demograph
date
ill
onset
clinic
symptom
exposur
histori
initi
visit
household
contact
gather
data
ill
sinc
exposur
casepati
type
pattern
exposur
eg
sleep
room
night
daili
contact
within
feet
direct
skintoskin
contact
kiss
hug
casepati
subsequ
visit
collect
inform
symptom
experienc
casepati
household
contact
sinc
previou
visit
includ
symptom
current
visit
specimen
collect
part
diagnost
workup
avail
investig
postenrol
visit
particip
ask
provid
wholeblood
serum
stool
urin
nasopharyng
oropharyng
swab
specimen
obtain
ml
blood
adult
ml
blood
children
year
old
venipunctur
finger
stick
clot
blood
centrifug
serum
separ
ship
cdc
test
similar
volum
whole
blood
collect
tube
contain
edta
nasopharyng
oropharyng
sampl
collect
use
singl
dacron
swab
nonwooden
shaft
swab
place
steril
vial
contain
ml
viral
transport
medium
stool
specimen
collect
steril
contain
seal
particip
provid
cleancatch
collect
urin
steril
urin
cup
specimen
process
store
accord
cdc
laboratori
biosafeti
guidelin
specimen
store
maximum
h
ship
ice
cdc
laboratori
ship
within
h
feasibl
specimen
store
ship
detect
sarscov
stool
urin
respiratori
specimen
perform
revers
transcriptasepolymeras
chain
reaction
rtpcr
use
primer
target
polymeras
nucleocapsid
gene
sarscov
genom
describ
elsewher
emeri
et
al
unpub
data
stool
sampl
prepar
extract
trishcl
buffer
isol
total
nucleic
acid
rtpcr
test
quantifi
viru
load
respiratori
stool
specimen
quantit
rtpcr
perform
use
taqman
assay
standard
curv
gener
synthet
rna
transcript
monro
r
beard
unpub
data
previous
describ
cultur
techniqu
use
isol
sarscov
specimen
determin
n
gene
sequenc
sarscov
set
overlap
rtpcr
product
cover
entir
open
read
frame
product
n
product
gene
gener
use
superscript
onestep
rtpcr
platinum
taq
invitrogen
carlsbad
ca
sequenc
use
gene
n
gene
sequenc
primer
tong
et
al
unpub
data
serum
specimen
test
sarscovassoci
antibodi
use
enzymelink
immunosorb
assay
indirect
fluoresc
antibodi
test
use
previous
describ
method
serum
specimen
consid
posit
result
test
posit
use
predetermin
cutoff
five
seven
enrol
casepati
provid
data
residu
symptom
three
casepati
report
short
breath
persist
least
day
respect
onset
fever
two
casepati
report
residu
cough
casepati
report
dri
cough
day
casepati
report
product
cough
day
onset
fever
symptom
report
acut
phase
casepati
ill
wheez
develop
one
casepati
without
previou
histori
respiratori
diseas
day
ill
persist
least
day
data
avail
character
progress
symptom
time
respiratori
specimen
obtain
seven
casepati
tabl
sputum
sampl
two
casepati
casepati
casepati
sarscov
detect
rtpcr
viral
cultur
sputum
sampl
casepati
collect
day
ill
onset
figur
respiratori
specimen
includ
seven
nasopharyng
oropharyng
swab
sampl
collect
first
week
ill
five
casepati
test
neg
rtpcr
total
stool
specimen
obtain
seven
casepati
two
patient
provid
sampl
one
patient
sampl
four
sampl
sarscov
rna
detect
five
specimen
came
two
casepati
one
specimen
casepati
four
specimen
casepati
figur
singl
posit
stool
specimen
casepati
obtain
day
onset
subsequ
stool
specimen
collect
day
test
neg
sarscov
rtpcr
first
stool
specimen
casepati
collect
day
ill
viral
rna
detect
four
stool
includ
last
one
collect
day
sarscov
isol
cultur
rtpcrposit
stool
specimen
highest
concentr
sarscov
detect
sputum
casepati
million
copi
per
gram
specimen
stool
casepati
million
copi
per
gram
specimen
tabl
day
ill
concentr
viru
stool
specimen
casepati
drop
note
casepati
report
moder
diarrhea
day
ill
casepati
mild
diarrhea
first
day
ill
amount
viru
stool
sampl
collect
day
ie
week
resolut
diarrhea
approxim
lower
amount
stool
sampl
casepati
approxim
lower
found
subsequ
specimen
casepati
evid
found
viru
mutat
casepati
infect
genom
sequenc
n
gene
sarscov
posit
stool
specimen
casepati
ident
viral
rna
detect
rtpcr
eight
urin
specimen
collect
seven
casepati
sarscov
antibodi
first
found
earli
day
ill
onset
three
seven
casepati
adequ
specimen
avail
character
time
first
detect
sarscov
antibodi
remain
four
casepati
respiratori
specimen
includ
np
nasopharyng
swab
nw
nasal
wash
nasal
aspir
op
oropharyng
swab
sp
sputum
stool
urin
block
symbol
denot
sarscovposit
specimen
rtpcr
ten
household
contact
five
seven
sar
casepati
enrol
casepati
four
household
contact
casepati
one
contact
casepati
two
household
contact
household
contact
femal
smoker
report
previou
histori
respiratori
problem
sarcoidosi
household
contact
pulmonari
embolu
household
contact
household
contact
also
casepati
contact
test
posit
sarscov
antibodi
remain
nine
household
contact
neg
sarscov
antibodi
specimen
collect
day
initi
exposur
casepati
infect
household
contact
wife
confirm
sar
casepati
coupl
visit
hong
kong
togeth
earli
march
stay
hotel
subsequ
link
initi
spread
sar
multipl
opportun
exposur
casepati
becam
ill
day
return
unit
state
hong
kong
symptom
develop
household
contact
day
return
unit
state
day
onset
ill
husband
sarslik
symptom
develop
three
household
contact
casepati
laboratori
evid
sarscov
infect
analysi
household
exposur
protect
measur
household
indic
household
contact
frequent
unprotect
contact
index
patient
compar
three
household
contact
tabl
remain
six
uninfect
household
contact
report
close
contact
eg
contact
within
feet
unprotect
skintoskin
contact
casepati
exposur
four
household
contact
two
casepati
stool
specimen
posit
sarscov
limit
isol
casepati
separ
room
privat
bathroom
first
week
ill
casepati
also
wore
surgic
mask
period
three
four
household
contact
casepati
hospit
day
day
ill
period
highest
amount
viru
detect
stool
continu
posit
sarscov
stool
discharg
neither
casepati
two
household
contact
wore
surgic
mask
discharg
hospit
casepati
never
hospit
lowlevel
shed
sarscov
stool
day
viru
subsequ
found
stool
specimen
one
two
household
contact
wore
mask
day
resolut
fever
casepati
investig
us
sarscovinfect
person
household
contact
identifi
probabl
transmiss
sarscov
contact
detect
sarscov
fecal
respiratori
specimen
found
sar
casepati
may
high
concentr
viru
stool
week
ill
continu
shed
viru
fece
least
day
onset
symptom
amount
sarscov
stool
casepati
moder
diarrhea
similarli
high
quantiti
seen
sputum
specimen
collect
differ
casepati
interv
ill
onset
howev
viru
could
cultur
stool
specimen
pcrposit
sarscov
suggest
sarscov
fece
may
present
form
either
nonviabl
viral
particl
antibodyco
viru
one
household
contact
becam
infect
person
contact
potenti
sourc
casepati
first
week
ill
member
household
contact
also
expos
hong
kong
along
husband
howev
becam
ill
day
return
unit
state
previous
report
data
suggest
incub
period
sar
rang
day
case
incub
period
may
long
day
therefor
possibl
remain
contact
may
infect
hong
kong
remain
uninfect
household
contact
includ
four
contact
two
casepati
posit
stool
specimen
whose
household
simpl
infectioncontrol
procedur
implement
acut
phase
ill
index
patient
lack
widespread
household
transmiss
sar
found
investig
similar
find
report
outbreak
toronto
household
contact
infect
despit
unprotect
contact
sar
casepati
philippin
nonhospit
contact
report
infect
find
support
idea
certain
circumst
sarscov
easili
transmit
transmiss
may
also
like
occur
time
patient
shed
higher
amount
viru
period
may
coincid
hospit
thu
decreas
degre
exposur
household
contact
unabl
detect
sarscov
specimen
casepati
day
ill
onset
detect
viru
three
casepati
sputum
sampl
one
patient
day
stool
sampl
two
patient
day
upper
respiratori
specimen
first
week
onset
neg
sarscov
rtpcr
find
differ
report
hong
kong
viral
rna
detect
nasopharyng
aspir
casepati
day
inabl
detect
viru
earli
respiratori
sampl
may
associ
type
nasopharyng
oropharyng
swab
versu
nasopharyng
aspir
collect
specimen
well
low
amount
viru
gener
seen
specimen
sputum
sampl
may
higher
concentr
viru
upper
respiratori
specimen
consist
find
stool
specimen
found
posit
frequent
upper
respiratori
specimen
week
ill
accord
limit
result
studi
inabl
detect
sarscov
urin
may
result
late
collect
urin
specimen
day
ill
onset
wider
use
steroid
treatment
persist
respiratori
symptom
report
least
month
onset
casepati
similar
symptom
observ
avendano
et
al
studi
canadian
healthcar
worker
follow
week
ill
onset
suggest
residu
ill
sar
casepati
howev
progress
symptom
time
difficult
interpret
without
better
appreci
preill
symptom
antibodi
sarscov
casepati
document
earli
day
ill
onset
adequ
number
earli
serum
specimen
casepati
determin
sarscov
antibodi
first
detect
result
investig
interpret
light
sever
limit
small
number
particip
allow
accur
estim
risk
transmiss
household
member
irregular
long
interv
collect
specimen
permit
clear
pictur
natur
histori
sarscov
infect
includ
document
precis
time
first
appear
sarscov
antibodi
also
may
miss
presenc
shed
stool
casepati
report
diarrhea
acut
phase
ill
possibl
variat
specimen
collect
handl
techniqu
could
also
affect
sarscov
detect
rate
respiratori
stool
specimen
result
suggest
sarscov
alway
transmit
effici
routin
collect
test
stool
sputum
specimen
probabl
sar
casepati
may
help
earli
detect
sarscov
infect
followup
recov
sar
casepati
sever
month
would
also
help
better
assess
possibl
wane
antibodi
titer
longterm
sequela
diseas
thu
improv
understand
true
ill
associ
sarscov
infect
